Dergiler / art / 2018 / Cilt: 33 - Sayı: 4

A Cross Sectional Study of the Impact of Human Immunodeficiency Virus, Hepatitis B Virus and Hepatitis C Virus on Rheumatoid Factor Production

Dergi
art
Sayfa
402–407
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Increased IgM-RF production may contribute to cytotoxicity in tissues or organs of HCV-infected patients, leading to the onset of autoimmune diseases.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: This study aims to investigate how human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) affect the production of immunoglobulin M (IgM)-rheumatoid factor (RF).
📊
Temel Bulgular & Veri:Patients and methods: The study included 405 voluntary participants (139 males, 266 females; mean age 39.4±17.9 years; range 3 to 88 years) randomly recruited by a consecutive sampling technique in the main health facilities of the Center, East, Far North, Littoral and West regions of Cameroon.
💡
Sonuç & Katkı:Increased IgM-RF production may contribute to cytotoxicity in tissues or organs of HCV-infected patients, leading to the onset of autoimmune diseases.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: This study aims to investigate how human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) affect the production of immunoglobulin M (IgM)-rheumatoid factor (RF). Patients and methods: The study included 405 voluntary participants (139 males, 266 females; mean age 39.4±17.9 years; range 3 to 88 years) randomly recruited by a consecutive sampling technique in the main health facilities of the Center, East, Far North, Littoral and West regions of Cameroon. We excluded persons under treatment or hospitalized for any form of primary autoimmune disease. Blood samples were collected and used for serological analyses. We sought for the HIV antibodies (Ab); the core antibody (HBcAb), the surface antigen (HBsAg), and the replicative antigen (HBeAg) of the HBV; HCVAb of HCV and the IgM-RF. Results: The prevalence of HIVAb was 7.61%, 38.7% for HBcAb, 5.43% for HBsAg, 1.26% for HBeAg and 6.41% for IgM-RF in the study population. The Far North region had the highest prevalence of IgM-RF (9.8%) and the Littoral region had the lowest prevalence (3.2%). The prevalence of RF was 6.7% and 5.7% for females and males, respectively (sex ratio of 2.25). The IgM-RF prevalence was 9.7%, 8.9%, 9.1%, and 27.8% in participants with positive serological results for HIVAb, HBcAb, HBsAg, and HCV, respectively. Conclusion: Infection by HIV and HBV showed to poorly stimulated IgM-RF production. However, IgM-RF was highly produced in HCV infected participants. Increased IgM-RF production may contribute to cytotoxicity in tissues or organs of HCV-infected patients, leading to the onset of autoimmune diseases.

🔖

Bu Makaleye Atıf Yap

PHILEMON, E. A., TUME, C., ASSOUMOU, M. C. O., BONSI, S. T., GEORGES, I. M., FOTSO, H. O., EMILYA, L., MARTHA, M. T., NGANDEU-SINGWE, M. (2018). A Cross Sectional Study of the Impact of Human Immunodeficiency Virus, Hepatitis B Virus and Hepatitis C Virus on Rheumatoid Factor Production. art, Cilt: 33 - Sayı: 4, 402–407. https://ajindex.com/articles/152556

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Mannik M, Nardella FA, Sasso EH. Rheumatoid factors in immune complexes of patients with rheumatoid arthritis. Springer Semin Immunopathol 1988;10:215-30
  2. Preud’homme JL, Clot J, Pasquali Jl, Youinou P, Saraux A, LeGoff P, et al. Autoimmunité et Autoanticorps. Cahier de Formation. Autoimmunité. 1999;13:1-24
  3. Janeway CA, Travers P, Walport M, Shlomchik MJ. Immunobiologie. 6th ed. New York: Garland Science; 2009
  4. Morel J, Combe B. How to predict prognosis in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 2005;19:137-46
  5. Comparing adult antenatal-clinic based HIV prevalence with prevalence from national population based surveys in Sub-Saharan Africa. Available from: http://data.unaids.org/pub/presentation/2007/ survey_anc_2007_en.pdf UNAIDS; 2007
  6. Viatte S, Flynn E, Lunt M, Barnes J, Singwe-Ngandeu M, Bas S, et al. Investigation of Caucasian rheumatoid arthritis susceptibility loci in African patients with the same disease. Arthritis Res Ther 2012;14:R239
  7. Atabonkeng EP Adiogo D, Emmanuel EM, Herve OF, Owono AM, Okomo Assoumou MC. Evaluation of the prevalence of rheumatoid factor in five regions of Cameroon. Arch Rheumatol 2013;30:226-30
  8. Devouassoux G. Physiopathologie des Hypersensibilités de type III-Immunologie et Mécanismes Immunopathologiques. CHLS et INSERM. 2010;23:3-5
  9. Armengaud JB, Deslandre C. Les arthrites juvéniles idiopathiques: formes oligoarticulaires, Diagnostic et modalités évolutives. Mt pédiatrie 2006;9:3-9
  10. Sany J. La polyarthrite rhumatoïde de l’adulte: Conception actuelle. Montrouge: John Libbey- Eurotext; 2003
  11. Önen F, Türkay C, Meydan A, Dökmeta HS, Sümer H, Hocao¤lu L, et al. Prevalence of rheumatoid factor (RF) and anti-native-DNA antibodies (anti-nDNA) in different age subpopulations. Turk J Med Sci 1998;28:85-8
  12. Hayahara C, Ikeda K, Sakanishi Y, Ota T. Incidence of serum rheumatoid factors in elder non-rheumatic individuals. Rinsho Byori 2010;58:211-5. [Abstract] 13. Gaston JSH. Rheumatic diseases - immunological mechanisms and prospects for new therapies. J Clin Immunol 1999;162:704-10
  13. Menzel EJ, Zlabinger GJ, Dunky A, Steffen C. Autoimmunity and T-cell subpopulations in old age. Arch Gerontol Geriatr 1988;7:249-60
  14. Båve U, Nordmark G, Lövgren T, Rönnelid J, Cajander S, Eloranta ML, et al. Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism. Arthritis Rheum 2005;52:1185-95
  15. Gottenberg JE, Cagnard N, Lucchesi C